Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Randomized Double-Blind Placebo-Controlled Study of Talniflumate in Cystic Fibrosis
2004-004334-13Phase 2Completed
- Sponsor
- Genaera Corporation
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cystic fibrosis (CF) comparing Talniflumate with Placebo (2 arms). Started Dec 2004; status: completed.
02
Drugs
talniflumate
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2004-004334-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004334-13.